{"lastClose": 45.209999084472656, "len": 2431, "date": "2022-11-11", "alpha_5": -0.10273124678228052, "beta_5": 0.9709434813623603, "drawup_5": 1.7682365503305206, "sharpe_5": 0.2306748638515639, "natr_5": 6.572331247727589, "sup_5": -0.21167882965321777, "res_5": 0.5222296192980991, "bullPattern_5": [], "bearPattern_5": ["SPINNINGTOP"], "rsi_5": 47.81291773694834, "adx_5": 10.250260961417627, "drawdown_5": -0.6982669918542315, "alpha_1": -0.3831304164913144, "beta_1": 0.9284543603750381, "drawup_1": 0.869131776727466, "sharpe_1": -0.8776192838178214, "natr_1": 6.572331247727589, "sup_1": -0.21757719608073117, "res_1": 0.23571485425651084, "bullPattern_1": ["CLOSINGMARUBOZU", "LONGLINE"], "bearPattern_1": ["TASUKIGAP"], "rsi_1": 39.961015943754525, "adx_1": 55.34392217537075, "drawdown_1": -0.5881399836468242, "alpha_3mo": -0.8700781360917017, "beta_3mo": 1.1196590963204751, "drawup_3mo": 0.10133982764258853, "sharpe_3mo": -3.4091922502708734, "natr_3mo": 6.572331247727589, "sup_3mo": -0.07498339876792279, "res_3mo": 0.04755588518950718, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 49.24379944623449, "adx_3mo": 43.281282797815315, "drawdown_3mo": -0.41797816606356986, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Name": "Enanta Pharmaceuticals Inc.", "IPO Year": 2013.0, "Market Cap": 936971282, "Country": "United States", "Sector": "Health Care", "alpha%_5": 0.10740023808648047, "beta%_5": 0.4271189352525253, "drawup%_5": 0.3119183768820388, "sharpe%_5": 0.29677328132962044, "natr%_5": 0.969175771894097, "drawdown%_5": 0.3263768197293292, "alpha%_1": 0.2861584126147582, "beta%_1": 0.45633414990022964, "drawup%_1": 0.9046109567804013, "sharpe%_1": 0.17927426110567563, "natr%_1": 0.8245420841409146, "drawdown%_1": 0.22195734446604648, "alpha%_3mo": 0.0895450810666153, "beta%_3mo": 0.6216498463166436, "drawup%_3mo": 0.15501109818182612, "sharpe%_3mo": 0.016642513514010134, "natr%_3mo": 0.8235645155125115, "drawdown%_3mo": 0.04794147161849647}